Watchlist Price Alert

Roivant Sciences Ltd. (ROIV)

NASDAQ: ROIV · Real-Time Price · USD

11.07

-0.25 (-2.21%)

At close: Jun 16, 2025, 3:59 PM

10.98

-0.86%

Pre-market: Jun 17, 2025, 04:16 AM EDT

Roivant Sciences Balance Sheet Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Cash & Equivalents	2.72B	1.99B	1.97B	5.68B	6.54B	6.67B	1.41B	1.43B	1.68B	1.53B
Short-Term Investments	2.17B	3.16B	3.43B	n/a	5.37M	5.17M	5.47M	-10.29M	n/a	n/a
Long-Term Investments	302.94M	290.04M	319.52M	262.98M	247.75M	239.93M	250.39M	306.53M	304.32M	282.1M
Other Long-Term Assets	32.86M	33.88M	28.73M	23.43M	39.11M	46.85M	49.8M	36.02M	49.48M	36.59M
Receivables	n/a	143.78M	22.68M	82.81M	63.19M	54.62M	39.91M	39.91M	37.64M	29.45M
Inventory	n/a	n/a	n/a	34M	35.25M	5.24M	4.91M	4.22M	2.76M	n/a
Other Current Assets	113.17M	16.02M	325.66M	17.59M	28.59M	17.68M	13M	13M	20.54M	15.87M
Total Current Assets	5B	5.36B	5.8B	6B	6.73B	6.81B	1.55B	1.56B	1.8B	1.65B
Property-Plant & Equipment	101.08M	104.46M	56.65M	63.15M	65.95M	68.75M	73.11M	87.9M	92.34M	91.93M
Goodwill & Intangibles	n/a	n/a	n/a	136.01M	137.84M	150.41M	140.62M	145.04M	144.88M	146.1M
Total Long-Term Assets	436.88M	428.38M	404.91M	494.95M	490.65M	505.95M	513.92M	575.49M	591.02M	556.73M
Total Assets	5.44B	5.79B	6.21B	6.5B	7.22B	7.31B	2.07B	2.14B	2.39B	2.2B
Account Payables	23.69M	23.71M	25.13M	27.74M	35.23M	35.23M	44.12M	50.03M	37.83M	48M
Deferred Revenue	1.17M	n/a	3.41M	2.66M	4.17M	4.7M	5.8M	10.57M	12.44M	7.8M
Short-Term Debt	n/a	9.84M	n/a	12M	45.71M	49M	44.41M	44.41M	40.72M	49.59M
Other Current Liabilities	53.93M	68.08M	473.93M	85.94M	82.17M	89.13M	138.59M	107.48M	74.84M	91.32M
Total Current Liabilities	149.41M	141.48M	556.25M	215.04M	266.76M	244.9M	265.55M	245M	272.45M	244.25M
Long-Term Debt	90.33M	90.48M	n/a	430.59M	403.34M	389.44M	385.07M	385.07M	375.51M	375.12M
Other Long-Term Liabilities	10M	24.41M	26.55M	29.34M	32.8M	45.12M	37.48M	120.62M	80.58M	101.52M
Total Long-Term Liabilities	100.33M	114.89M	69.74M	386.12M	507.19M	483.2M	474.36M	557.5M	509.57M	531.57M
Total Liabilities	249.74M	256.38M	625.99M	601.16M	773.95M	728.1M	739.91M	802.51M	782.02M	775.82M
Total Debt	100.17M	100.31M	52.71M	379.06M	499.75M	506.58M	497.98M	492.63M	481.4M	479.64M
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	116.06M	460.4M	395.58M	671.47M	576.17M	727.29M	-4.37B	-4.06B	-3.77B	-3.74B
Comprehensive Income	9.44M	8.06M	-18.04M	-17.95M	-4.08M	-27.78M	-3.07M	-6.61M	-2.62M	-729K
Shareholders Equity	4.69B	5.19B	5.58B	5.44B	5.97B	6.09B	948.53M	910.73M	1.16B	955.52M
Total Investments	2.47B	3.45B	3.75B	262.98M	247.75M	239.93M	250.39M	296.24M	304.32M	282.1M